Delivery Order SPE2DB20D7066-SPE2DB25FC3SE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,081.17 to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count supply) on June 18, 2025, with completion scheduled for June 20, 2025. This firm fixed-price delivery order, placed without set-aside provisions, represents a competitive award to the prime contractor, which maintains its corporate headquarters in Conshohocken, Pennsylvania—the designated place of performance. The award is executed under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,351.88 to AmerisourceBergen Drug Corp for the supply of Valacyclovir HCL 1 gram tablets (90-count units) on September 5, 2025, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents performance at the contractor's facility in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count) with a ceiling value of $1,421.78. The award was issued on August 27, 2025, with an ultimate completion date of August 28, 2025, under a firm fixed-price contract structure with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 2, 2025, for the supply of Valacyclovir HCL 1 gram tablets (90-count package). The contract, valued at $6,306.47, carries a firm fixed price and represents a non-set-aside competitive award. The product is to be delivered to the Conshohocken, PA location with an ultimate completion date of September 3, 2025. This delivery order is issued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 1, 2025, for Valacyclovir HCL 1 Gram Tablet 90s. The contract is valued at $1,327.44 with a firm fixed price structure and an ultimate completion date of August 4, 2025. This is a non-set-aside competitive award, reflecting AmerisourceBergen's capability to compete openly for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,848.18 to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count supply) on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,701.77 to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count) with an ultimate completion date of September 5, 2025. This firm fixed-price delivery order, awarded on September 4, 2025, represents a non-competitive set-aside award under the company's larger contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order valued at $2,592.05 to AmerisourceBergen Drug Corp for Valacyclovir HCL 500 mg tablets (90-count) on September 18, 2025, with an ultimate completion date of September 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through an open procurement process. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,066.16 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Valacyclovir HCL 1 Gram Tablets (90-count packages). This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a pediatric or routine pharmaceutical procurement under the DLA's Medical Supply Chain operations. The award was made on a competitive basis with no set-aside designation, leveraging...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valacyclovir HCL 1 gram tablets (90-count) with a ceiling value of $1,359.47 under a firm fixed price contract type. The award was made on September 4, 2025, with an ultimate completion date of September 5, 2025. This is a non-set-aside competitive award, and performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC3SEDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,589.52 for Valacyclovir HCl 1 gram tablets (90-count packaging) on June 12, 2025, with completion scheduled for June 13, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor and critical vendor for federal military and veteran healthcare procurement needs. The parent IDC vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. This delivery order for an antiviral medication reflects the company's ongoing role as a key supplier within DLA's pharmaceutical supply chain, supporting military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 6/12/25 |